Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Natural History Data of International Subjects With an ULTRA-Rare Neuro Developmental Disorder as Part of the ENCORE Expert Clinics, Specifically CAMK2A, CAMK2B, CAMK2D, and CAMK2G.

NCT07372833 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT07372833
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07372833 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Natural History Data of International Subjects With an ULTRA-Rare Neuro Developmental Disorder as Part of the ENCORE Expert Clinics, Specifically CAMK2A, CAMK2B, CAMK2D, and CAMK2G.
Lead sponsor
Erasmus Medical Center
Phase
Observational
Overall status
Recruiting
Start date
February 9, 2021
Completion date
January 1, 2040
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

calcium/calmodulin-dependent protein kinase 2, camk2